BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2952268)

  • 1. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 2. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
    Clark D; White FJ
    Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 4. D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.
    Barone P; Braun AR; Chase TN
    Clin Neuropharmacol; 1986; 9 Suppl 4():128-30. PubMed ID: 2952266
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-1 and D-2 receptor manipulation in Cebus monkeys: implication for extrapyramidal syndromes in humans.
    Gerlach J; Casey D; Kistrup K
    Clin Neuropharmacol; 1986; 9 Suppl 4():131-3. PubMed ID: 2952267
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
    Andersen PH; Nielsen EB; Scheel-Krüger J; Jansen JA; Hohlweg R
    Eur J Pharmacol; 1987 Jun; 137(2-3):291-2. PubMed ID: 2956116
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 12. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.
    Arnt J
    Psychopharmacology Suppl; 1985; 2():60-1. PubMed ID: 3159011
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
    Barone P; Tucci I; Parashos SA
    Ann Ist Super Sanita; 1988; 24(4):547-50. PubMed ID: 3265291
    [No Abstract]   [Full Text] [Related]  

  • 19. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.